Ad5-CD/TKrep
AXP000049.1 · Oncolytic virus
- Platform
- adenovirus (Ad5, replication-competent, E1B-55kDa retained)
- Originator
- Henry Ford Health
- Sponsor
- Henry Ford Health
Names
| Name | Type | Source |
|---|---|---|
| Ad5-CD/TKrep | preferred name, code | curator, paper |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5 (CD/TKrep)
- Replication
- replicating
- Modifications
- replication-competent Ad5 carrying a cytosine deaminase/HSV-1 thymidine kinase fusion gene
- Transgenes
- CD/HSV-1 TK suicide-gene fusion
- Route
- intratumoral
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 14612551 | Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. | Cancer research | 2003 | name in abstract: Ad5-CD/TKrep |
| PMID 12208748 | Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. | Cancer research | 2002 | name in abstract: Ad5-CD/TKrep |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 16290236 | Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. | Molecular therapy : the journal of the American Society of Gene Therapy | 2006 | name in abstract: Ad5-CD/TKrep |
| PMID 16555996 | Cancer scene investigation: how a cold virus became a tumor killer. | Future oncology (London, England) | 2005 | name in abstract: Ad5-CD/TKrep |
| PMID 12377341 | Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. | International journal of radiation oncology, biology, physics | 2002 | name in abstract: Ad5-CD/TKrep |
| PMID 10646640 | Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. | Human gene therapy | 2000 | name in abstract: Ad5-CD/TKrep |
| PMID 10933942 | Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse. | Molecular therapy : the journal of the American Society of Gene Therapy | 2000 | name in abstract: Ad5-CD/TKrep |
NIH grants
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| P01CA097012 | Second Generation Adenoviral Vectors for Cancer Therapy | HENRY FORD HEALTH SYSTEM | FREYTAG, SVEND O | 2004–2008 | name in abstract: Ad5-CD/TKrep |
| R21CA085551 | PHASE I STUDY OF COMBINED VIRAL & SUICIDE GENE THERAPIES | HENRY FORD HEALTH SYSTEM | FREYTAG, SVEND O | 1999–2000 | name in abstract: Ad5-CD/TKrep |
Notes
First-generation Henry Ford replication-competent adenovirus carrying a cytosine deaminase/HSV-1 thymidine kinase fusion gene, given intraprostatically with 5-FC/ganciclovir and radiotherapy from 1999. Construct details not re-verified against the primary trial report.
How to cite
Ad5-CD/TKrep (AXP000049.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000049.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.